Search results

• Site visit to Sederma Beauty Actives business in France

  17-18 March 2016: Croda International plc hosted a Capital Markets Event for analysts and investors at its Sederma facility near Versailles, France.

• Analyst consensus

  Consensus collated from estimates submitted by side-sell analysts on Croda International Plc.

• Our Board activity in 2025

  An update from Croda’s 2025 Annual Report on Board governance and culture, highlighting leadership, accountability and the values guiding long-term sustainable growth.

• Finance review 2025

  “With a comprehensive transformation programme that is driving both growth and efficiencies, we are firmly focused on execution. Progress so far has been encouraging, and we are setting out a financial framework to full year 2028 that outlines further improvements in financial performance.”

• Life Sciences business review - rebalancing Pharma and driving differentiation in Agriculture

  Discover how Life Sciences is rebalancing Pharma and driving differentiation in Agriculture. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

• Industrial Specialties business review

  Discover how Industrial Specialties is enabling continued growth, exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

• Consumer Care sustainability review

  Connecting sustainability to people, making it personal, is core to the sustainability focus within the Consumer Care business. Consumers desire personal care products that deliver performance, without negatively impacting the planet. Keeping this at the core creates value for our customers’ brands and the consumers they serve.

• Sustainability Progress Statement

  Explore our 2025 Sustainability Progress Statement to see how we’re driving measurable progress on climate action, responsible sourcing, and social impact, creating sustainable solutions that deliver lasting value for our customers, communities, and the planet.

• Climate Positive

  By 2030, we will be Climate Positive.

• India

  Croda India's manufacturing site was founded in 1995 and is located at Navi Mumbai.

• Greater China

  Croda has been present in China since 1993.

• Singapore

  Croda Singapore was founded in 1986 and is the regional headquarters of the Asia Pacific region.

• Croda named Britain’s Most Admired Chemicals Company for the tenth time, extending an exceptional record of sustained peer recognition

  20 January 2026: Croda International Plc has been named Britain’s Most Admired Chemicals Company for the tenth time, highlighting its leadership in smart science and high-performance ingredients.

• Croda at a glance

  At Croda, we are driven by our Purpose, to use smart science to create high-performance ingredients and technologies that improve lives.

• Croda acquired crop enhancement company Plant Impact

  Plant Impact identifies ways to improve the yield and quality of crops by stimulating or moderating plant responses in both healthy and stressed crops during key growth stages.

• Acquisition of global vaccine adjuvant specialist

  Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.

• Croda acquires marine biotechnology specialists Nautilus

  World class scientists, focusing on using marine microbial biodiversity to discover novel actives and materials for applications across all Croda market sectors.

• Croda acquires Inventiva, encapsulation and delivery system technology

  It will form the basis of a research and technology platform for the encapsulation and delivery of Croda’s products, providing a new dimension in the company’s innovation programme.

• Croda acquires research enterprise Enza Biotech

  Developing the next generation of renewable surfactants using carbohydrate-based chemistry.

• Croda expands Iberchems fragrances offering with the acquisition of Parfex

  Croda has acquired a controlling majority 95.6% of Parfex’s outstanding shares, comprising the founding shareholders and certain minority investors.